India is again in news for its policy on compulsory license. After being in news for issuing first of a compulsory license on Nexavar, Indian government has decided to issue compulsory license for three more drugs (Indian Express news) which are related to the treatment of cancer. The three anticancer drugs that are the [...]
In a recent decision, Intellectual Property Appellate Board (IPAB) invalidated Pegasys patent from Roche (judgment available here), which was also India’s first product patent after introduction of patents in pharmaceutical products. It’s a landmark decision because it is the first decision in post grant opposition. It is another blow to big pharma world after [...]
The global pharmaceutical market is witnessing a change as many patents of key blockbuster drugs have expired in last few years. The patent expiration of blockbuster drug fuel the growth of global generic drug pharmaceutical market. Many branded pharmaceutical companies drugs expired in last few years like Lipitor, Cozaar, Concerta, Crestor, Levaquin and Zyprexa. [...]
Kenyan court’s recent orders can brighten up the generic drug makers’ prospects in African market. The Kenya High Court has ruled that the government must review Kenya’s Anti Counterfeit Act, 2008, a legislation that could threaten the import of generic medicines. The court has ordered the Kenyan government to make amendments to the Act [...]
Drug maker Venus Remedies Ltd has been granted a patent by Indian authorities for its once-a-day painkiller Aceclofenac injection. Aceclonefac is world's first once-a-day painkiller injection.Aceclofenac is a NSAID (non steroidal anti inflammatory drug) used for the relief of acute as well as chronic pain and inflammation in rheumatoid arthritis, osteoarthritis, low back pain, ankylosing [...]
